Summary
Injection sclerotherapy is the mainstay of treatment for acute variceal bleeding and for long-term management after a variceal bleed. In those few patients in whom sclerotherapy fails to control acute bleeding, either a surgical shunt or a simple esophageal transection is recommended. A surgical shunt or a more extensive esophagogastric evascularization and transection operation is advocated for the failures of long-term sclerotherapy management. The role of pharmacological agents in acute variceal bleed management remains in question, and the use of propranolol in long-term management, either as an alternative to sclerotherapy or in combination with sclerotherapy, is controversial. The definitive roles of the newly described variceal banding and transjugular intrahepatic portosystemic shunts (TIPS) procedures have yet to be established. All patients presenting with end-stage liver disease and esophageal variceal bleeding should be evaluated for a liver transplant, although few will qualify. A possible future transplant should be kept in mind when emergency treatment is planned. Any form of prophylactic therapy for patients with esophageal varices that have not yet bled will remain unjustified until those patients at high risk of a first variceal bleed can be identified. The gastric mucosal lesion, portal hypertensive gastropathy, has been underdiagnosed in the past. Although bleeding does occur, it is seldom a major clinical problem. When necessary, bleeding can be controlled by propranolol or a surgical shunt.
Similar content being viewed by others
References
Adam R, Diamond T, Bismuth H (1992) Partial portacaval shunt: renaissance of an old concept. Surgery 111: 610–616
Anonymous (1991) Portal hypertensive gastropathy. Lancet 338: 1045–1046
Anonymous(1992) Bleeding oesophageal varices: IST, EVL, or TIPs. Lancet 340: 515–516
Beppu K, Inokuchi K, Koyanagi N, Nakayama S, Sakata H, Kitano S, Kobayashi M (1981) Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 27: 213–218
Bornman PC, Terblanche J, Kahn D, Jonker MA, Kirsch RE (1986) Limitations of multiple injection sclerotherapy sessions for acute variceal bleeding. S Afr Med J 70: 34–36
Burroughs AK, Hamilton G, Phillips A, Mezzanotte G, McIntyre N, Hobbs KEF (1989) A comparison of sclerotherapy with staple transection of the esophagus for the emergency control of bleeding from esophageal varices. N Engl J Med 321: 857–862
Burroughs AK, McCormick PA, Hughes MD, Sprengers D, D'Heygere F, McIntyre N (1990) Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding. Gastroenterology 99: 1388–1395
Conn HO (1993) Transjugular intrahepatic portal-systemic shunts: The state of the art. Hepatology 17: 148–158
Dasarathy S, Dwivedi M, Bhargava DK, Sundaram KR, Ramachandran K (1992) A prospective randomized trial comparing repeated endoscopic sclerotherapy and propranolol in decompensated (Child Class B and C) cirrhotic patients. Hepatology 16: 89–94
De Franchis R, Primignani M, Arcidiacono PG, Rizzi PM, Vitagliano P, Vazzoler MC, Arcidiacono R, Rossi A, Zambelli A, Cosentino F, Caletti G, Brunati S, Battaglia G, Gerunda G (1991) Prophylactic sclerotherapy in high-risk cirrhotics selected by endoscopic criteria. A multicenter randomized controlled trial. Gastroenterology 101: 1087–1093
Dudley FJ (1992) Somatostatin and portal hypertensive bleeding: A safe therapeutic alternative? Gastroenterology 103: 1973–1977
Fleig WE, Stange EF, Hunecke R, Schonborn W, Hurler U, Rainer K, Gaus W, Ditschuneit H (1987) Prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage: Prospective randomized comparison of propranolol and sclerotherapy. Hepatology 7: 355–361
Gimson A, Polson R, Westaby D, Williams R (1990) Omeprazole in the management of intractable esophaeal ulceration following injection sclerotherapy. Gastroenterology 99: 1829–1831
Haskal ZJ, Ring EJ, La Berge JM, Peltzer MY Radosevich PM, Doherty MM, Gordon RL (1992) Role of parallel transjugular intrahepatic portosystemic shunts in patients with persistent portal hypertension. Radiology 185: 813–817
Hayes PC, Davis JM, Lewis JA, Bouchier IAD (1990) Meta-analysis of value of propranolol in prevention of variceal haemorrhage. Lancet 336: 153–156
Henderson JM, Gilmore GT, Hooks MA, Galloway JR, Dodson TF, Hood MM, Kutner MH, Boyer TD (1992) Selective shunt in the management of variceal bleeding in the era of liver transplantation. Ann Surg 216: 248–255
Hwang S-J, Lin H-C, Chang C-F, Lu F-Y, Lee C-W, Hsia H-C, Wang S-S, Lee S-D, Tsai Y-T, Lo K-J (1992) A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding. J Hepatol 16: 320–325
Infante-Rivard C, Esnaola S, Villeneuve JP (1989) Role of endoscopic variceal sclerotherapy in the long-term management of variceal bleeding: A meta-analysis. Gastroenterology 96: 1087–1092
Inokuchi K and Cooperative Study Group of Portal Hypertension of Japan (1990) Improved survival after prophylactic portal nondecompression surgery for esophageal varices: A randomized clinical trial. Hepatology 12: 1–6
Iwatsuki S, Starzl TE, Todo S, Gordon RD, Tzakis AG, Marsh JW, Makowka L, Koneru B, Stieber A, Klintmalm G, Husberg B, van Thiel D (1988) Liver transplantation in the treatment of bleeding esophageal varices. Surgery 104: 697–705
Jenkins SA, Shields R, Jaser N, Ellenbogen S, Makin C, Naylor E, Newtead M, Baxter JN (1991) The management of gastrointestinal haemorrhage by somatostatin after apparently successful endoscopic injection sclerotherapy for bleeding oesophageal varices. J Hepatol 12: 296–301
Jensen LS, Krarup N (1989) Propranolol in prevention of rebleeding from oesophageal varices during the course of endoscopic sclerotherapy. Scand J Gastroenterol 24: 339–345
Kahn D, Bornman PC, Terblanche J (1989) A 10-year prospective evaluation of balloon tube tamponade and emergency injection sclerotherapy for actively bleeding esophageal varices. HPB Surg 1: 207–219
Kahn D, Jones B, Bornman PC, Terblanche J (1989) Incidence and management of complications after injection sclerotherapy: a 10-year prospective evaluation. Surgery 105: 160–165
Kaye GL, McCormick A, Siringo S, Hobbs KEF, McIntyre N, Burroughs AK (1992) Bleeding from staple line erosion after esophageal transection: Effect of omeprazole. Hepatology 15: 1031–1035
Kitano S, Koyanagi N, Iso Y, Higashi H, Sugimachi K (1987) Prevention of recurrence of esophageal varices after endoscopic injection sclerotherapy with ethanolamine oleate. Hepatology 7: 810–815
Kitano S, Iso Y, Hashizume M, Yamaga H, Koyanagi N, Wada H, Iwanaga T, Ohta M, Sugimachi K (1992) Sclerotherapy vs. esophageal transection vs. distal splenorenal shunt for the clinical management of esophageal varices in patients with Child Class A and B liver function: A prospective randomized trial. Hepatology 15: 63–68
Kleber G, Sauerbruch T, Fischer G, Geigenberger G, Paumgartner G (1991) Reduction of transmural oesophageal variceal pressure by metoclopramide. J Hepatol 12: 362–366
La Berge JM, Ring EJ, Lake JR, Ferrell LD, Doherty MM, Gordon RL, Roberts JP, Peltzer MY, Ascher N (1992) Transjugular intrahepatic portosystemic shunts: Preliminary results in 25 patients. J Vasc Surg 16: 258–267
Marbet UA, Straumann A, Gyr KE, Beglinger C, Schaub N, Vogtlin J, Loosli J, Kiowski W, Ritz R, Stalder GA (1988) Reduction in early recurrence of variceal bleeding by propranolol. Scand J Gastroenterol 23: 369–374
McCormick PA, Kaye GL, Greenslade L, Cardin F, Hobbs KEF, McIntyre N, Burroughs AK (1992) Esophageal staple transection as a salvage procedure after failure of acute injection sclerotherapy. Hepatology 15: 403–406
Orloff MJ, Orloff MS, Rambotti M. Girard V (1992) Is portal-systemic shunt worthwhile in Child's Class C cirrhosis? Long-term results of emergency shunt in 94 patients with bleeding varices. Ann Surg 216: 256–268
Pagliaro L, D'Amico G, Sorensen TIA, Lebrec D, Burroughs AK, Morabito A, Tine F, Politi F, Traina M (1992) Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of non-surgical treatment. Ann Intern Med 117: 59–70
Perez-Ayuso RM, Pique JM, Bosch J, Panes J, Gonzalez A, Perez R, Rigau J, Quintero E, Valderrama R, Viver J, Esteban R, Rodrigo L, Bordas JM, Rodes J (1991) Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet 337: 1431–1434
Reveille RM, Goff JS, Stiegmann GV, Stauffer JT (1991) Combination endoscopic variceal ligation (EVL) and low-volume endoscopic sclerotherapy (ES) for bleeding esophageal varices: a faster route to variceal eradication? Gastrointest Endosc 37: 243 (Abstr)
Rikkers LF, Jin G, Burnett DA, Bucki KN, Cormier RA (1993) Shunt surgery versus endoscopic sclerotherapy for variceal hemorrhage: Late results of a randomized trial. Amer J Surg 165: 27–33
Saeed ZA, Michaletz PA, Winchester CB, Woods KL, Dixon WB, Heiser MC, Gentry KR, Ramirez FC (1990) Endoscopic variceal ligation in patients who have failed endoscopic sclerotherapy. Gastrointest Endosc 36: 572–574
Sarfeh IJ, Rypins EB, Mason GR (1986) A systematic appraisal of portacaval H-grafts diameters. Clinical and hemodynamic perspectives. Ann Surg 204: 356–363
Shields R, Jenkins SA, Baxter JN (1992) A prospective randomised controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices. J Hepatol 16: 128–137
Spina GP, Henderson JM, Rikkers LF, Teres J, Burroughs AK, Conn HO, Pagliaro L, Santambrogio R (1992) Distal splenorenal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding. A meta-analysis of four randomized clinical trials. J Hepatol 16: 338–345
Stiegmann GV, Goff JS (1988) Endoscopic esophageal varix ligation (EDL): preliminary clinical experience. Gastrointest Endosc 34: 105–108
Stiegmann GV, Goff JS, Michaletz-Onody PA, Korula J, Lieberman D, Saeed ZA, Reveille RM, Sun JH, Lowenstein SR (1992) Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 326: 1527–1532
Sugiura M, Futagawa S (1984) Results of six hundred and thirty-six esophageal transections with paraesophagogastric devascularization in the treatment of esophageal varices. J Vasc Surg 1: 254–260
Taranto D, Suozzo R, de Sio I, Romano M, Caporaso N, Blanco CDV, Coltorti M (1990) Effect of metoclopramide on transmural oesophageal variceal pressure and portal blood flow in cirrhotic patients. Digestion 47: 56–60
Terblanche J, Kahn D, Campbell JAH, Bornman PC, Jonker MAT, Wright J, Kirsch RE (1983) Failure of repeated injection sclerotherapy to improve long-term survival after oesophageal variceal bleeding. A five-year prospective controlled clinical trial. Lancet 2: 1328–1332
Terblanche J (1989) The surgeon's role in the management of portal hypertension. Ann Surg 209: 381–395
Terblanche J, Burroughs AK, Hobbs KEF (1989) Controversies in the management of bleeding esophageal varices. N Engl J Med 320: 1393–1398; 1469–1475
Terblanche J, Kahn D, Bornman PC (1989) Long-term injection sclerotherapy treatment for esophageal varices: a 10-year prospective evaluation. Ann Surg 210: 725–731
Terblanche J (1990) Has sclerotherapy altered the management of patients with variceal bleeding? Amer J Surg 160: 37–42
Terblanche J, Krige JEJ, Bornman PC (1992) The treatment of esophageal varices. Annu Rev Med 43: 69–82
The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices (1988) Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices: a prospective multicenter study. N Engl J Med 319: 983–989
The Prova Study Group (1991) Prophylaxis of first hemorrhage from esophageal varices by sclerotherapy, propranolol or both in cirrhotic patients: A randomized multicentre trial. Hepatology 14: 1016–1024
The Veterans Affairs Cooperative Variceal Sclerotherapy Group (1991) Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease. A randomized, single-blind, multicenter clinical trial. N Engl J Med 324: 1779–1784
Triger DR, Johnson AG, Brazier JE, Johnston GW, Spencer EFA, McKee R, Anderson JR, Carter DC (1992) A prospective trial of endoscopic sclerotherapy v oesophageal transection and gastric devascularization in the long-term management of bleeding oesophageal varices. GUT 33: 1553–1558
Triger DR, Smart HL, Hosking SW, Johnson AG (1991) Prophylactic sclerotherapy for esophageal varices: Long-term results of a single-center trial. Hepatology 13: 117–123
Vinel JP, Lamouliatte H, Cales P, Combis J-M, Roux D, Desmorat H, Pradere B, Barjonnet G, Quinton A, Pascal J-P (1992) Propranolol reduces the rebleeding rate during endoscopic sclerotherapy before variceal obliteration. Gastroenterology 102: 1760–1763
Warren WD, Henderson JM, Millikan WJ, Galambos JT, Brooks WS, Riepe SP, Salam AA, Kutner MH (1986) Distal splenorenal shunt versus endoscopic sclerotherapy for long-term management of variceal bleeding: preliminary report of a prospective, randomized trial. Ann Surg 203: 454–462
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Terblanche, J. Portal hypertension management. Surg Endosc 7, 472–478 (1993). https://doi.org/10.1007/BF00316683
Issue Date:
DOI: https://doi.org/10.1007/BF00316683